Stay updated on Fostamatinib in wAIHA Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib in wAIHA Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record presents a completed Phase 3 trial of fostamatinib for warm antibody autoimmune hemolytic anemia, including its eligibility criteria, study locations, treatment arms, and outcome measures.
    Difference
    85%
    Check dated 2026-11-09T13:51:28.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    An NIH notice about updates to its websites and terminology appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-26T14:29:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:23:39.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:40:10.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, blocking access to the content and preventing the study details from loading.
    Difference
    17%
    Check dated 2026-09-21T22:13:39.000Z thumbnail image

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.